With a test that produces objective data, the test informs critical medical decision-making. This potentially reduces long-term risks like Chronic Traumatic Encephalopathy (CTE).

Every day, the lack of reliable medical testing facilities forces hundreds of Afghans to seek treatment abroad for diseases that are easily detected in clinical laboratories in neighboring countries.

South Shore Health's Dr. Todd Ellerin says FDA-approved at-home tests are trustworthy and can be used by patients on their own. Ellerin encourages people to still visit a physician even after ...

A new,  blood-based method of analysing thousands of proteins in a single, untargeted test will greatly help the diagnosis of rare diseases in babies and children, avoiding what is sometimes ...

Joe Biden was not screened for prostate cancer during his four years as president, in line with medical recommendations for men 70 or older.

Following a nearly two-week hiatus in the trial of Aaron Thomas, a doctor specializing in child abuse testified that only trained medical professionals should examine children for puberty development.

Roche’s companion test aims to identify non-small cell lung cancer patients who may benefit from Datroway, from AstraZeneca and Daiichi Sankyo.

This means good diagnostic tests are the most likely to give you a clear answer without causing physical harm and can be used to make medical decisions about your next steps, according to the article.

Artificial Intelligence is now helping to interpret complicated medical test results. The simple effects earned a local medical student a place in history. Tyler Smith is a Northwestern Student ...

HealthDay News — The new International League Against Epilepsy (ILAE) definition of epilepsy results in a higher frequency of epilepsy diagnosis and treatment, according to a study published ...

A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic dermatitis and psoriasis in a skin biopsy, according to a press ...

A new antibody testing strategy using tissue transglutaminase antibodies at 6.1 times the upper limit of normal can improve celiac disease diagnosis in patients with T1D, according to a Swiss study.